. RLS in stenotic vs non-stenotic segments 0.78, p<0.004). Furthermore, RLS predicted significant stenosis in corresponding coronary arteries (Figure 1) .
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Saphenous vein graft intervention versus percutaneous coronary intervention for the native coronary artery in patients with prior coronary artery bypass grafting K. Yamaji 1 , T. Kimura 2 , M. Nobuyoshi 1 on behalf of j-Cypher Registry. 1 Kokura Memorial Hospital, Kitakyushu, Japan;
2 Kyoto University Graduate School of Medicine, Kyoto, Japan Purpose: PCI in patients with prior CABG was still challenging for lesions with saphenous vein grafts (SVG). The clinical outcomes following PCI for prior CABG patients were not fully elucidated. Methods: We conducted a post-hoc subgroup analysis of 5-year follow-up data of j-Cypher Registry. Of the 12812 patients (19662 lesions) who treated with at least one SES, 919 patients (7.2%) with 1369 lesions (7.0%) had a history of CABG. Among patients with a history of CABG, 26 patients who underwent PCI for at least one arterial graft were excluded for the analysis. The current study population comprised of remaining 122 patients who underwent PCI for at least one saphenous vein graft (SVG group) and 711 patients who underwent PCI for the native coronary artery (Native group). Results: Patients characteristics were similar between patients in the SVG group and those in the Native group except for the prevalence of acute coronary syndrome presentation (32 [26.2%] Background: The measurement of deformation parameters -Strain (S) and Strain Rate (SR) -allows the quantitative analysis of myocardial function. There is still a paucity of data concerning regional deformation during Dobutamine Stress Echocardiography (DSE) and little is known about potential differences of basal, midventricular and apical segments of the Left Ventricle (LV). Aim: Our aim was to assess regional values of longitudinal S and SR in 18 segments of LV during baseline and peak stage of DSE and change of these parameters between baseline and peak using Speckle Tracking Echocardiographic quantification (STE) and Automated Function Imaging (AFI). Methods: 238 patients were examined by DSE with acquisition of high temporal resolution data. The whole group had the coronary anatomy status established by angiography or computed tomography. A subset of 111 patients without significant coronary lesions was selected for this analysis: 68 female, mean age 60±10 years.
Results: The significant dispersion of strain values among the LV segments (measured both by AFI and STE and confirmed by ANOVA, p<0.0001) was observed during baseline and peak stage of DSE. The comparison of changes in strain between peak and baseline stage showed reduction in strain amplitude of basal and mid-ventricular segments and increased amplitude of strain in apical segments of the LV. Contrarily, absolute values of SR increased during DSE in all segments. Dispersion of the change in strain and designation of segments are presented in Figure. Conclusions: We observed opposite direction of the longitudinal strain changes during DSE between apical and basal 2/3 part of myocardium. This significant dispersion among nonischemic LV segments must be considered in LV function quantification during stress echo.
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Predictive values of hemoglobinA1c and 1,5-anhydro-d-glucitol for the SYNTAX score and prevalence of coronary artery disease N. Ikeda, H. Hara, Y. Hiroi. National Center for Global Health and Medicine, Cardiology Division, Tokyo, Japan
Purpose: HemoglobinA1c (HbA1c) is associated with an increased risk of Coronary Artery Disease (CAD). Serum 1,5-Anhydro-d-Glucitol (1,5-AG) levels rapidly decrease concomitantly with the excretion of glucose in urine, and serum 1,5-AG is a useful clinical marker for short-term glycemic status. 1,5-AG reflects glycemic excursions more sensitively than HbA1c, especially in the postprandial state. Postprandial hyperglycemia is one of the important risk of CAD. The aim of this study is to compare HbA1c with 1,5-AG as the predictor of CAD. Methods: The subjects were 273 consecutive patients who underwent their first coronary angiography from July 2011 to January 2013. The relationship between prevalence of CAD and HbA1c or 1,5-AG levels were evaluated. The correlation between complexity of CAD and HbA1c or 1,5-AG were also assessed. The complexity of CAD was evaluated by the SYNTAX score. The complex-lesion was defined as the SYNTAX score ≥23 according to previous studies.
Results:
The patients with CAD presented significantly higher HbA1c and lower 1,5-AG levels than the patients without CAD (6.4±1.2 vs. 6.0±0.9 p=0.0005, 12.8±8.3 vs. 18.2±9.3 p<0.0001, respectively). 1,5-AG was an independent predictor of CAD even coronary risk factors (include diabetes mellitus) were adjusted (Odds ratio:0.931, 95% CI:0.897-0.966, p=0.0001). In contrast, HbA1c did not present significant predictive value of CAD in the adjusted model. The areas under the receiver-operating characteristic curves (AUC) of HbA1c and 1,5-AG to predict CAD were 0.632 (95% CI:0.565-0.699, p<0.0001) and 0.674 (95% CI:0.611-0.738, p<0.0001), respectively. In contrast, HbA1c showed higher AUC than 1,5-AG when they predict complex-lesions (the SYNTAX score ≥23) (HbA1c: 0.656, 95% CI 0.565-0.748 p=0.002 and 1,5-AG: 0.617, 95% CI 0.528-0.706 p=0.016). Both HbA1c and 1,5-AG presented significant correlation between the SYNTAX score (ρ=0.286, p=0.0002 and ρ=-0.188, p<0.0001, respectively). Conclusions: 1,5-AG level independently predicted prevalence of CAD, and the predictive value was stronger than that of HbA1c. In contrast, HbA1c may be more effective to predict complex-lesions than 1,5-AG. Both HbA1c and 1,5-AG levels showed significant correlation with the SYNTAX score. Purpose: Coronary artery disease (CAD) patients have increased levels of thrombotic and inflammatory biomarkers, impaired endothelial function and characterized by increased incidence of myocardial infarction (MI). Fibrinogen is important inflammatory biomarker. However the impact genetic variability of fibrinogen in inflammatory and coagulation processes and endothelial function remains unknown. Therefore, we investigated whether a genetic polymorphism on fibrinogen beta chain (G455A) affects specific parameters of the aforementioned processes. Methods: Genotyping was performed in 456 CAD patients and 272 controls. The G455A polymorphism was determined by polymerase chain reaction (PCR) and the specific HaeIII restriction enzyme. Fibrinogen were measured by the von Clauss method. IL-6 and sCD40L levels were assessed by ELISA, while endothelial function was measured by FMD of the brachial artery. Results: Genotype distribution was GG: 54.6%, GA: 36.8%, AA: 8.6% for controls and GG: 50.1%, GA: 42.0%, AA: 7.9% for CAD. In CAD patients, 455AA homozygotes had lower FMD (%) than 455G carriers, however this difference was not significant (2.8±2.2 vs 2.9±1.8, p=NS), while this occurred also in controls (5.7±2.7 vs 6.5±6.1 for AA vs G allele carriers, p=NS). Although interleukin 6 levels were increased in patients with CAD compared to controls (4.40±3.13 vs 3.41±2.76, p<0.01), the G455A polymorphism did not affect IL-6 levels (GG+GA vs AA) both in CAD and controls (p=NS). In a similar way, sCD40L levels were significantly higher in CAD compared to controls (2.07±1.47 vs 1.82±1.68, p<0.001). No difference was observed in sCD40L across the study genotypes both in controls and in CAD (p=NS). Importantly, the present polymorphism modified significantly fibrinogen levels (GG+GA vs AA) not only in controls (366.6±85.8 vs 439.1±122.3, p<0.05), but also in CAD (426.0±122.7 vs 521.8±113.1, p<0.001). Finally, no difference was observed in CAD patients for the incidence of previous MI between 455G carriers and 455AA homozygotes (OR: 0.640. 95% CI (0.1328-3.085), p=NS).
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Genetic variability of fibrinogen affects differentially inflammation, coagulation and endothelial function of patients with advanced atherosclerosis
Conclusions:
The G455A genetic polymorphism does not modify inflammatory process and endothelial function. However, it has a significant impact on fibrinogen levels both in controls and in patients with coronary artery disease. Our findings suggest that the G455A polymorphism disturbs the coagulation process and promotes atherosclerosis, through its significant effect on fibrinogen.
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Lower Background: Gender differences in treatment and outcome of patients with coronary artery disease especially with acute coronary syndromes have been well described. Little is known about the impact of gender on long-term outcome of patients with stable coronary artery disease (CAD) in clinical practice. Methods: Between Sept 2001 and March 2003, a total of 2,002 consecutive patients with angina pectoris and first angiographic diagnosis of CAD were enrolled in the STAR-Registry (50 centres). We examined the impact of gender on 5-yearmortality of stable CAD in clinical practice in Germany. Results: Of 2002 patients with stable CAD, 600 patients (30.0%) were female, 1402 male (70.0%). Female patients were 5 years older and more often had diabetes. No differences were observed in other co-morbidities. Female patients less often had multi-vessel disease and impaired LV-EF as compared to male patients. Female patients were more likely to undergo repeated subsequent PCI during the 5-year follow-up, and less likely to be referred to CABG. In univariate analysis female patients had similar 5-year mortality as compared to male patients. However, after correction for differences in age, prevalence of diabetes, impaired LV-EF as well as for revascularisation therapy, female gender was associated with lower 5-year mortality in stable CAD in clinical practice (OR 0.75, 
Conclusion:
Female gender was associated with a 25% lower 5-year mortality rate in patients with stable coronary artery disease in clinical practice. 
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